Loading chat...
ME LD582
Bill
AI Summary
-
Health insurance carriers in Maine must cover blood testing for PFAS (perfluoroalkyl and polyfluoroalkyl substances) when recommended by a provider as medically necessary
-
PFAS blood testing is presumed medically necessary when a patient meets clinical guidelines established by the National Academies of Sciences, Engineering, and Medicine
-
Health plans cannot impose deductibles, copayments, coinsurance, or other cost-sharing for covered PFAS blood testing, except for health savings account-compatible plans pending IRS guidance
-
Requirements apply to all health policies issued or renewed on or after January 1, 2026
-
Legislature finds coverage does not expand the state's essential health benefits, avoiding state cost defrayal requirements under the Affordable Care Act
Legislative Description
An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances
Insurance
Last Action
CARRIED OVER, in the same posture, to any special or regular session of the 132nd Legislature, pursuant to Joint Order SP 800.
6/25/2025